Skip to main content
Erschienen in: Pediatric Nephrology 12/2023

10.07.2023 | Original Article

Longitudinal changes of health-related quality of life in childhood chronic kidney disease

verfasst von: Joann Carlson, Arlene C. Gerson, Matthew B. Matheson, Sharon Manne, Marc Lande, Lyndsay Harshman, Rebecca J. Johnson, Shlomo Shinnar, Amy J. Kogon, Bradley Warady, Susan Furth, Stephen Hooper

Erschienen in: Pediatric Nephrology | Ausgabe 12/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Few longitudinal studies have evaluated the impact of chronic kidney disease (CKD) duration on health-related quality of life (HRQOL). The study’s aim was to determine how HRQOL changes over time in childhood CKD.

Methods

Study participants were children in the chronic kidney disease in children (CKiD) cohort who completed the pediatric quality of life inventory (PedsQL) on three or more occasions over the course of two or more years. Generalized gamma (GG) mixed-effects models were applied to assess the effect of CKD duration on HRQOL while controlling for selected covariates.

Results

A total of 692 children (median age = 11.2) with a median of 8.3 years duration of CKD were evaluated. All subjects had a GFR greater than 15 ml/min/1.73 m2. GG models with child self-report PedsQL data indicated that longer CKD duration was associated with improved total HRQOL and the 4 domains of HRQOL. GG models with parent-proxy PedsQL data indicated that longer duration was associated with better emotional but worse school HRQOL. Increasing trajectories of child self-report HRQOL were observed in the majority of subjects, while parents less frequently reported increasing trajectories of HRQOL. There was no significant relationship between total HRQOL and time-varying GFR.

Conclusions

Longer duration of the disease is associated with improved HRQOL on child self-report scales; however, parent-proxy results were less likely to demonstrate any significant change over time. This divergence could be due to greater optimism and accommodation of CKD in children. Clinicians can use these data to better understand the needs of pediatric CKD patients.

Graphical abstract

Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Gerson AC, Butler R, Moxey-Mims M, Wentz A, Shinnar S, Lande MB, Mendley SR, Warady BA, Furth SL, Hooper SR (2006) Neurocognitive outcomes in children with chronic kidney disease: current findings and contemporary endeavors. Ment Retard Dev Disabil Res Rev 12:208–215. https://doi.org/10.1002/mrdd.20116CrossRefPubMed Gerson AC, Butler R, Moxey-Mims M, Wentz A, Shinnar S, Lande MB, Mendley SR, Warady BA, Furth SL, Hooper SR (2006) Neurocognitive outcomes in children with chronic kidney disease: current findings and contemporary endeavors. Ment Retard Dev Disabil Res Rev 12:208–215. https://​doi.​org/​10.​1002/​mrdd.​20116CrossRefPubMed
7.
Zurück zum Zitat Francis A, Didsbury MS, van Zwieten A, Chen K, James LJ, Kim S, Howard K, Williams G, Bahat Treidel O, McTaggart S, Walker A, Mackie F, Kara T, Nassar N, Teixeira-Pinto A, Tong A, Johnson D, Craig JC, Wong G (2019) Quality of life of children and adolescents with chronic kidney disease: a cross-sectional study. Arch Dis Child 104:134–140. https://doi.org/10.1136/archdischild-2018-314934CrossRefPubMed Francis A, Didsbury MS, van Zwieten A, Chen K, James LJ, Kim S, Howard K, Williams G, Bahat Treidel O, McTaggart S, Walker A, Mackie F, Kara T, Nassar N, Teixeira-Pinto A, Tong A, Johnson D, Craig JC, Wong G (2019) Quality of life of children and adolescents with chronic kidney disease: a cross-sectional study. Arch Dis Child 104:134–140. https://​doi.​org/​10.​1136/​archdischild-2018-314934CrossRefPubMed
9.
11.
Zurück zum Zitat Selewski DT, Troost JP, Massengill SF, Gbadegesin RA, Greenbaum LA, Shatat IF, Cai Y, Kapur G, Hebert D, Somers MJ, Trachtman H, Pais P, Seifert ME, Goebel J, Sethna CB, Mahan JD, Gross HE, Herreshoff E, Liu Y, Song PX, Reeve BB, DeWalt DA, Gipson DS (2015) The impact of disease duration on quality of life in children with nephrotic syndrome: a midwest pediatric nephrology consortium study. Pediatr Nephrol 30:1467–1476. https://doi.org/10.1007/s00467-015-3074-xCrossRefPubMedPubMedCentral Selewski DT, Troost JP, Massengill SF, Gbadegesin RA, Greenbaum LA, Shatat IF, Cai Y, Kapur G, Hebert D, Somers MJ, Trachtman H, Pais P, Seifert ME, Goebel J, Sethna CB, Mahan JD, Gross HE, Herreshoff E, Liu Y, Song PX, Reeve BB, DeWalt DA, Gipson DS (2015) The impact of disease duration on quality of life in children with nephrotic syndrome: a midwest pediatric nephrology consortium study. Pediatr Nephrol 30:1467–1476. https://​doi.​org/​10.​1007/​s00467-015-3074-xCrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Lim HJ, Koo TY, Lee J, Huh KH, Park JB, Cho J, Lee S, Ro H, Han S, Park B, Park S, Chung W, Park SK, Kim C, Kim SJ, Kim YS, Ahn C, Yang J, KNOW-KT study group (2016) health-related quality of life of kidney transplantation patients: results from the Korean cohort study for outcome in patients with kidney transplantation (KNOW-KT) study. Transplant Proc 48:844–847. https://doi.org/10.1016/j.transproceed.2015.12.101CrossRefPubMed Lim HJ, Koo TY, Lee J, Huh KH, Park JB, Cho J, Lee S, Ro H, Han S, Park B, Park S, Chung W, Park SK, Kim C, Kim SJ, Kim YS, Ahn C, Yang J, KNOW-KT study group (2016) health-related quality of life of kidney transplantation patients: results from the Korean cohort study for outcome in patients with kidney transplantation (KNOW-KT) study. Transplant Proc 48:844–847. https://​doi.​org/​10.​1016/​j.​transproceed.​2015.​12.​101CrossRefPubMed
15.
Zurück zum Zitat Guha C, van Zwieten A, Khalid R, Kim S, Walker A, Francis A, Didsbury M, Teixeira-Pinto A, Barton B, Prestidge C, Lancsar E, Mackie F, Kwon J, Howard K, Mallitt KA, Howell M, Jaure A, Hayes A, Raghunandan R, Petrou S, Lah S, McTaggart S, Craig JC, Wong G (2023) Longitudinal assessment of the health-related quality of life of children and adolescents with chronic kidney disease. Kidney Int 103:357–364. https://doi.org/10.1016/j.kint.2022.09.026CrossRefPubMed Guha C, van Zwieten A, Khalid R, Kim S, Walker A, Francis A, Didsbury M, Teixeira-Pinto A, Barton B, Prestidge C, Lancsar E, Mackie F, Kwon J, Howard K, Mallitt KA, Howell M, Jaure A, Hayes A, Raghunandan R, Petrou S, Lah S, McTaggart S, Craig JC, Wong G (2023) Longitudinal assessment of the health-related quality of life of children and adolescents with chronic kidney disease. Kidney Int 103:357–364. https://​doi.​org/​10.​1016/​j.​kint.​2022.​09.​026CrossRefPubMed
25.
28.
Metadaten
Titel
Longitudinal changes of health-related quality of life in childhood chronic kidney disease
verfasst von
Joann Carlson
Arlene C. Gerson
Matthew B. Matheson
Sharon Manne
Marc Lande
Lyndsay Harshman
Rebecca J. Johnson
Shlomo Shinnar
Amy J. Kogon
Bradley Warady
Susan Furth
Stephen Hooper
Publikationsdatum
10.07.2023
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Nephrology / Ausgabe 12/2023
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-023-06069-8

Weitere Artikel der Ausgabe 12/2023

Pediatric Nephrology 12/2023 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Frühe Hypertonie erhöht späteres kardiovaskuläres Risiko

Wie wichtig es ist, pädiatrische Patienten auf Bluthochdruck zu screenen, zeigt eine kanadische Studie: Hypertone Druckwerte in Kindheit und Jugend steigern das Risiko für spätere kardiovaskuläre Komplikationen.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.